The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

KZR FINANCIAL STATEMENTS

Kezar Life Sciences Inc — balance sheet, income statement and cash flow trends

KZRKezar Life Sciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M-50 M0202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue0 $Gross Profit-403 K $ · -Infinity%Operating Income-42 M $ · -Infinity%Pre-tax Income-45.2 M $ · -Infinity%Net Income to Owners-45.2 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-403 K $—
Operating Income-42 M $—
EBITDA-31.7 M $—
Net Income to Owners-45.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M300 M202120222023202420252026

Capital Structure

Q1 2026
Total Assets68 M
  • Equity65.2 M $96%
  • Current Liabilities2.8 M $4%

Key Figures

YoY change
Total Assets68 M $-45.7%
Total Liabilities2.8 M $-87.6%
Total Equity65.2 M $-36.7%
Cash & ST Investments66.2 M $-42.1%
Total Debt1.4 M $-90.4%
Net Debt-64.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-75 M-50 M-25 M0202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
-25 M025 M-42 M $Operating80.3 M $Investing-9 M $Financing29.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-42 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-42 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on KZR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.